Intravenous drug use (IDU) poses severe health risks due to direct exposure to harmful substances and unhygienic practices. Common complications include infections like HIV, hepatitis B and C, and bacterial endocarditis. Non-sterile needles increase the risk of abscesses and vein damage. Long-term IDU often leads to systemic health issues, including cardiovascular and pulmonary complications. Harm reduction strategies, such as needle exchange programs and supervised injection sites, aim to mitigate these risks. Coupled with addiction treatment, these interventions improve health outcomes and reduce the societal burden of IDU-related complications.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Evaluation of prevalence and pattern of tobacco use in yenagoa city in bayelsa state south of nigeria
Owonaro Peter, Bayelsa State Drug Avuse Addiction Prevention and Rehabilitation Committee (BADAPARC), Nigeria
Title : Engaging learners through gamification, creativity, and human-centered design
Tero Moliis, Versantium, United States
Title : Neuropharmacological and regulatory drivers of tianeptine misuse in the united states: A growing public health concern
Darcy Tocci, NSU College of Pharmacy, United States
Title : Awakening sovereignty within: Healing trauma, releasing codependency, and returning to self-trust
Whitney Walker, Mental Health Therapist/ Podcast Host, United States
Title : You can save a life: Real conversations, real solutions for suicide prevention
frank King, The Mental Health Comedian, LLC, United States